Latest news

Clinical

Despite failing the phase 2 ALS investigation, Axoltis will continue using the synthetic peptide

Phase 2 Trial Overview and Primary Endpoint Results French biotech Axoltis Pharma may have failed to meet its primary endpoint...
Regulatory

BMS and Ono Challenge Amgen as Opdivo Biosimilar Nears FDA Review

Bristol Myers Squibb and Ono Pharmaceutical have filed a lawsuit against Amgen over its proposed biosimilar to the cancer...
Manufacturing

Reckitt Plans $600 Million U.S. Expansion Across Manufacturing and R&D

Reckitt is investing up to $600 million over several years to expand and modernize its U.S. operations, with the...
Insights

Top 10 Trends Driving Adaptive Clinical Trials

Executive Summary Clinical trials are becoming increasingly complex as pharmaceutical companies evaluate more targeted therapies, recruit diverse patient populations, and...
Regulatory

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Scholar Rock has received U.S. Food and Drug Administration...
Clinical

J&J’s Depression Drug Fails Another Phase 2 Test

A phase 2 study of Johnson & Johnson’s JNJ-5120...
Insights

Edge AI in Healthcare

Executive Summary Artificial intelligence is becoming increasingly embedded in healthcare, but many AI applications still depend on centralized cloud infrastructure...
Insights

Building a Future-Ready Life Sciences Organization

Executive Summary The life sciences industry is entering a period of structural change. Scientific innovation is accelerating, healthcare systems are becoming...
Regulatory

FDA Extends Review of Exelixis’ Zanzalintinib-Tecentriq Combination for Metastatic Colorectal Cancer

The U.S. Food and Drug Administration (FDA) has extended its review of Exelixis’ application for zanzalintinib in combination with...
Commercial

Building on a “centuries-old bond,” Singapore establishes a biotech-focused Boston hub

With the original site of the international hotel chain...
Clinical

The Definium LSD medication wins another crucial anxiety study, making it 3 for 3

Definium Therapeutics has once again won in a phase...
Insights

Top 10 AI Models Used in Drug Design

Executive Summary Artificial intelligence is changing drug design by enabling researchers to model biological structures, predict molecular interactions, generate new...
Insights

Why Multi-Omics Is Becoming a Strategic Priority in Life Sciences

Executive Summary Modern life sciences research is generating more biological data than ever before. Genomics has transformed the understanding of DNA,...
Clinical

AbbVie’s Phase 3 Victory Opens Door For Qulipta Expansion

AbbVie has cleared another hurdle in its effort to broaden the use of its migraine preventive Qulipta, or atogepant,...
Regulatory

BMS and Ono Challenge Amgen as Opdivo Biosimilar Nears FDA Review

Bristol Myers Squibb and Ono Pharmaceutical have filed a...
Editorial Team -
Commercial

Merck to pay Aqilion EUR 960 million in pre-clinical licensing and strategic research collaboration

Aqilion announced that it has successfully obtained an exclusive...
Commercial

Democrats demand US pharmaceutical companies on their plan to share vaccine IP as pandemic wreaks havoc in India

More than half of all the Americans would have been inoculated with at least one shot of the Covid-19 vaccine in the coming weeks.

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

BMS and Ono Challenge Amgen as Opdivo Biosimilar Nears FDA Review

Bristol Myers Squibb and Ono Pharmaceutical have filed a...
Editorial Team -
Regulatory

BMS and Ono Challenge Amgen as Opdivo Biosimilar Nears FDA Review

Bristol Myers Squibb and Ono Pharmaceutical have filed a...
Manufacturing

Reckitt Plans $600 Million U.S. Expansion Across Manufacturing and R&D

Reckitt is investing up to $600 million over several...
Insights

Top 10 Trends Driving Adaptive Clinical Trials

Executive Summary Clinical trials are becoming increasingly complex as pharmaceutical...
Clinical

Electra Plans to Advance Ipsoprubart Through Phase 2/3 sHLH Study

Electra Therapeutics plans to use proceeds from a proposed...

Research & Development

Market Access

Manufacturing

Takeda Plans 4,500 Job Cuts as CEO Transition and Three Drug Launches Approach

Takeda has outlined plans to reduce around 4,500 roles...
Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Manufacturing

ArsenalBio Lays Off 99 Employees and Shifts Focus to In Vivo CAR-T Programs

Arsenal Biosciences (ArsenalBio) is reducing its workforce by 99...
Editorial Team -